Latest news
New to The Street NASDAQ MARKETSITE - ACCESS NewswireACCESS Newswire · Sat, 08 Aug 2026 16:03:05 GMTNew to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results - guardonline.comguardonline.com · Sat, 08 Aug 2026 16:01:36 GMTStudy identifies promising therapy to prevent relapses in rare neurological disease - Medical XpressMedical Xpress · Fri, 07 Aug 2026 12:00:03 GMTNew heart drug targeting inflammation falls short in clinical trial - Cardiovascular BusinessCardiovascular Business · Thu, 06 Aug 2026 20:22:24 GMTBioVie’s stock sinks 50% as company uses composite endpoint to make case for Parkinson’s program - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 13:40:09 GMTAssessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in Immunology - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 10:58:36 GMTPainful swelling and misdiagnoses disrupted daily life in Pharvaris study - Stock TitanStock Titan · Thu, 06 Aug 2026 10:50:00 GMTSanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’ - Fierce BiotechFierce Biotech · Wed, 05 Aug 2026 18:50:22 GMT